On December 20th, 2018, Matt Epplin successfully defended his thesis, “The Design, Synthesis, and Biological Evaluation of Subunit-Selective Modulators of the N-Methyl-D-Aspartate Receptor”. Matt’s thesis committee included his advisor, Dr. Dennis Liotta and members Dr. Frank McDonald, Dr. David Lynn, and Dr. Stephen Traynelis.
During his time at Emory, he developed chemical tools for NMDA towards understanding neuropsychiatric disease. Now, Matt is looking forward to starting his postdoc at Stanford with Dr. Noah Burns.
Congratulations, Dr. Epplin!